TY - ADVS
T1 - Back cover: Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak-Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
AU - Li, Jiachen
AU - Huang, Di
AU - Cheng, Ruoyu
AU - Figueiredo, Patrícia
AU - Fontana, Flavia
AU - Correia, Alexandra
AU - Wang, Shiqi
AU - Liu, Zehua
AU - Kemell, Marianna
AU - Torrieri, Giulia
AU - Mäkilä, Ermei M.
AU - Salonen, Jarno J.
AU - Hirvonen, Jouni
AU - Gao, Yan
AU - Li, Jialiang
AU - Luo, Zhenyang
AU - Santos, Hélder A.
AU - Xia, Bing
N1 - https://doi.org/10.1002/adma.202270074
PY - 2022/3/3
Y1 - 2022/3/3
N2 - Nanovaccines A cancer cell membrane@porous silicon nanoparticles@Au nanovaccine is developed by Zhenyang Luo, Hélder A. Santos, Bing Xia, and co-workers in article number 2108012, based on weak-immunostimulatory porous silicon@Au nanoparticulate cores and multi-antigenic cancer cell membranes. These exogenous nanovaccines boost antitumor immunity, preventing the occurrence of solid tumors, and significantly inhibiting the growth and metastasis of solid tumors after photothermal therapy combined with immune checkpoint inhibitors.
AB - Nanovaccines A cancer cell membrane@porous silicon nanoparticles@Au nanovaccine is developed by Zhenyang Luo, Hélder A. Santos, Bing Xia, and co-workers in article number 2108012, based on weak-immunostimulatory porous silicon@Au nanoparticulate cores and multi-antigenic cancer cell membranes. These exogenous nanovaccines boost antitumor immunity, preventing the occurrence of solid tumors, and significantly inhibiting the growth and metastasis of solid tumors after photothermal therapy combined with immune checkpoint inhibitors.
KW - antitumor immune response
KW - biomimetic nanovaccines
KW - cancer cell membranes
KW - photothermal synergized immunotherapy
KW - porous silicon@Au nanocomposites
U2 - 10.1002/adma.202270074
DO - 10.1002/adma.202270074
M3 - Digital or Visual Products
ER -